Learn more →
Back to Expert Scholars
gi-oncology / gi-oncologyHepatocellular Carcinoma

Jean-Luc Raoul

让-吕克·拉乌尔

MD

🏢Institut Paoli-Calmettes(保利-卡尔梅特癌症研究所)🌐France

Senior Medical Oncologist, Gastrointestinal Oncology消化道肿瘤科高级肿瘤内科医师

52
h-index
2
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Jean-Luc Raoul is a renowned French HCC specialist with deep expertise in locoregional therapies including TACE and systemic treatment sequencing. He has contributed to landmark European HCC clinical trials and served on major international guideline committees.

Share:

🧪Research Fields 研究领域

Hepatocellular Carcinoma肝细胞癌
Liver Cancer肝癌
TACE经动脉化疗栓塞
GI Oncology消化道肿瘤学

🎓Key Contributions 主要贡献

TACE in HCC

Advanced the clinical evidence base for transarterial chemoembolization, clarifying patient selection criteria and its role in BCLC intermediate-stage HCC.

Systemic Therapy Sequencing

Contributed to defining optimal sequencing strategies following TACE failure, bridging locoregional and systemic therapy paradigms.

HCC Clinical Trial Design

Participated in pivotal phase III HCC trials across Europe, influencing regulatory approvals and practice-changing treatment algorithms.

Representative Works 代表性著作

[1]

Chemoembolization as first-line treatment for hepatocellular carcinoma

Hepatology (2011)

Defined TACE efficacy and patient selection benchmarks that continue to inform intermediate-stage HCC management.

[2]

Sequential therapy in hepatocellular carcinoma after sorafenib failure

Annals of Oncology (2017)

Landmark analysis guiding second-line treatment decision-making after first-line sorafenib progression.

🏆Awards & Recognition 奖项与荣誉

🏆ASCO Merit Award
🏆SNFGE Research Prize
🏆FFCD Honorary Fellowship

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 让-吕克·拉乌尔 的研究动态

Follow Jean-Luc Raoul's research updates

留下邮箱,当我们发布与 Jean-Luc Raoul(Institut Paoli-Calmettes)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment